Bipolar Disorder

Psychiatric experts consider mood stabilizers when treating bipolar disorder and review the role of antidepressants in disease management.

Theresa Cerulli, MD, and Tina Matthew-Hayes, DNP, FNP, PMHNP, review diagnostic difficulties of the patient’s primary care physician in patient case #1 and share optimal approaches to the diagnosis and treatment for patients with bipolar disorder.

Tina Matthews-Hayes, DNP, FNP, PMHNP, comments on screening tools for bipolar disorder and Gustavo Alva, MD, DFAPA, shares his impressions from patient case #1.

A panel of experts in psychiatry share insights on the challenges and importance of making an accurate diagnosis of bipolar disorder.

Experts in psychiatry review the case of a 27-year-old woman who presents for evaluation of a complex depressive disorder.

How to regulate circadian rhythms and regulate mood using dark therapy.

Caplyta shows promise as a monotherapy for patients with bipolar I or bipolar II disorder experiencing a major depressive episode

At the Annual Psychiatric Times World CME Conference, an all-star lineup of presenters will share their latest research. Check out this preview of the full agenda.

Bipolar disorder and pregnancy: what considerations need to be kept in mind?

What are the greatest unmet mental health needs in the United States today? Recent statistics from the Centers for Disease Control may hold the answers.

Blue light is associated with a host of physical health maladies, including obesity, diabetes, and cancer. But what does it do to patients with depression or bipolar disorder?

A deep dive into the history, side effects, and efficacy of a controversial drug.

A rare robust finding from a study on bipolar depression.

This combination treatment of olanzapine and samidorphan caused significantly less weight gain in patients with schizophrenia and bipolar I disorder.

There is debate whether schizoaffective disorder is a separate illness or is part of the continuum of schizophrenia and mood disorder spectrum.

This treatment for agitation associated with schizophrenia and bipolar disorder is moving up the FDA ladder…

Although lithium is a first-line treatment that ranks high on the list of patient’s favorites, it has fallen out of general use, particularly in the United States. When lithium works well, its benefits tend to last. It is among the top medications that prevent hospitalization. More in this podcast.

A preview of 3 pivotal trials suggests promising results, but there are reasons to wait before jumping in with this antipsychotic.

Why does prazosin appear to be the safest and most effective medication for select patients with comorbid PTSD?

Despite recent advances in research on bipolar disorder, it remains a complex and even mysterious condition.

“As soon as Lexi reaches home, she abruptly sinks into depression and curls up in a fetal position, almost catatonic in her bed.”

Some mood episodes are more anxiety-provoking than others, and at the top of the list are mixed states.

A quick primer on nomenclature, issues to consider, and switching.

Prazosin appears to be effective and perhaps the best medication for selected patients, including those with bipolar disorder.

Is this treatment for bipolar disorder risking patients’ heart health?